Tumor News and Research

RSS

Breakthrough research could transform the landscape of ovarian cancer treatment

In a major scientific breakthrough, newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.

27 Feb 2024

Study demonstrates a feasible way to expand germline genetic testing for cancer patients

A new University of Kentucky Markey Cancer Center study published in JCO Precision Oncology demonstrates a feasible way to expand germline genetic testing for patients with cancer.

27 Feb 2024

Study finds metabolic checkpoint PHGDH as potential target to modulate tumor-associated macrophages

A study by a scientific team from the University of Vienna and the MedUni Vienna, recently published in the top-class journal Cellular & Molecular Immunology, has a promising result from tumor research: The enzyme phosphoglycerate dehydrogenase (PHDGH) acts as a metabolic checkpoint in the function of tumor-associated macrophages (TAMs) and thus on tumor growth.

27 Feb 2024

Flavonol-rich diet linked to lower mortality and disease risk, study shows

Study finds that higher dietary intake of flavonol is linked to reduced all-cause mortality and lower risk of Alzheimer's disease, cancer, and cardiovascular disease in US adults.

26 Feb 2024

Study reveals early death predictors in COVID-19 patients with cardiac injury

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The activation of immune and thrombotic biomarkers at admission, and their ability to predict cardiac injury and mortality patterns in COVID-19, remains unclear.

26 Feb 2024

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer.

26 Feb 2024

Study links ultra-processed foods to gut health risks

A review in Nature Reviews Gastroenterology & Hepatology synthesizes evidence on the negative impacts of ultra-processed foods and food additives on gut health, linking them to chronic diseases and alterations in the gut microbiome.

25 Feb 2024

Unlocking vitamin B6's role in pancreatic cancer and immune system battle

Vitamin B6 is beneficial in many ways, notably for its role in maintaining a strong immune system. However, when pancreatic cancer develops, its cells also need vitamin B6 to replicate.

23 Feb 2024

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Lung cancer is not the most common form of cancer, but it is by far the deadliest.

23 Feb 2024

Genetic signature may help predict disease-free survival in patients with non-small cell lung cancer

A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation.

23 Feb 2024

How did COVID-19 impact cancer incidence trends in the US?

Cancer rate patterns from March to December 2020.

23 Feb 2024

Off-the-shelf cancer vaccine shows promising results in patients with KRAS-mutated tumors

Samara Rahman, 74, considers herself lucky. She gets to take walks on the beach, go swimming and ride her bike -; all things that were taken from her when she was diagnosed with pancreatic cancer in November of 2022.

22 Feb 2024

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.

22 Feb 2024

Elevated IFN-γ levels linked to long COVID, study finds

Researchers find elevated IFN-γ levels in long COVID patients, with symptom improvement correlating with decreased IFN-γ, suggesting it as a potential biomarker and target for therapeutic intervention.

22 Feb 2024

New immunotherapy target activin receptor 1C shows promise against cancer

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

22 Feb 2024

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

22 Feb 2024

$Evaluating the efficacy of ultrahypofractionated whole breast irradiation in a FAST-Forward randomized trial$

Previous
1
...
12
13
14
15
16
17
18
...
1174
Next

Tumor News and Research

Breakthrough research could transform the landscape of ovarian cancer treatment

Study demonstrates a feasible way to expand germline genetic testing for cancer patients

Study finds metabolic checkpoint PHGDH as potential target to modulate tumor-associated macrophages

Flavonol-rich diet linked to lower mortality and disease risk, study shows

Study reveals early death predictors in COVID-19 patients with cardiac injury

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

Study links ultra-processed foods to gut health risks

Unlocking vitamin B6's role in pancreatic cancer and immune system battle

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Genetic signature may help predict disease-free survival in patients with non-small cell lung cancer

How did COVID-19 impact cancer incidence trends in the US?

Off-the-shelf cancer vaccine shows promising results in patients with KRAS-mutated tumors

Natural killer cells lead the charge in cancer treatment innovation

Elevated IFN-γ levels linked to long COVID, study finds

New immunotherapy target activin receptor 1C shows promise against cancer

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

Evaluating the efficacy of ultrahypofractionated whole breast irradiation in a FAST-Forward randomized trial

Study reveals unexpected link between cell membrane damage and cellular senescence

Can dietary patterns impact stomach cancer risk?

Scientists discover the Achilles heel of chemotherapy-resistant ovarian cancer

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News